SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceuticals informs about clarification

19 Feb 2025 Evaluate
Sandu Pharmaceuticals has informed about clarification for not filling consolidated financial for the Q ended 31st December 2024 due to not applicability of consolidated financials for the Q ended 31st December 2024 to the Company.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

38.40 0.40 (1.05%)
29-Jul-2026 15:17 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1991.05
Dr. Reddys Labs. 1142.10
Cipla 1473.00
Lupin 2444.20
Zydus Lifesciences 1121.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: